行业领先的治疗性急性伤口护理公司Avita Medical Inc (ASX股票代码:AVH)宣布已成功完成向澳洲机构和专业投资者的私募配售，以1.32澳元价格发行约1720万份新CDI，融资1500万美元（约合2300万澳元）。

所得款项预计可覆盖2026年开始产生自由现金流之前的运营资金需求。

AVITA Medical首席执行官Jim Corbett表示，配售结果反映出投资者对AVH发展战略和产品组合变革潜力的信心日益增强。

今年二季度AVH创销售收入1823万美元，同比增长21.2%。

周三AVH澳交所股价应声飙涨13.81%。

AVH最新价1.69澳元，已发行股本1.32亿股，市值2.23亿澳元。

截止上季度末AVH账面现金结余1221万美元。

（图片来源：AVH公告）

（图片来源：AVH官网）

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.